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uncompensated cirrhosis at MR imaging
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Abstract
Background: In order to retrospectively determine the frequency of dilated cisterna
chyli (CC) on MR images in patients with cirrhosis, and to assess its value as a
simple diagnostic imaging sign of uncompensated cirrhosis.
Methods: Study population included 257 patients (149 with pathologically proved
cirrhosis and 108 control subjects without the history of chronic liver diseases) who
had 1.5 T MR imaging. Cirrhosis patients were divided into compensated and
uncompensated groups. Three independent observers qualitatively evaluated the
visibility of CC 2 mm or greater in transverse diameter, identified as a tubular
structure with fluid signal intensity. CC diameters greater than 6 mm were defined as
dilated. Statistical analysis was performed by Student t-test and interobserver
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agreement via intraclass correlation coefficient.
Results: CCs with diameter 2 mm or more were recorded in 113 of 149 (76%)
cirrhotic patients and 15 of 108 (14%) control subjects (P < 0.001). Dilated CCs were
significantly more frequent in uncompensated than compensated cirrhotic patients
(54% vs 5%, P < 0.001). The sensitivity, specificity, accuracy, and positive predictive
value of dilated CC for uncompensated cirrhosis were 54%, 98%, 80%, and 96%,
respectively.
Conclusions: Dilated CC can be used as a simple and specific sign complimentary to
other findings of uncompensated cirrhosis.
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About 80% of the lymph formed in the liver leaves via hilar lymphatics and
enters the thoracic duct at or near the cisterna chyli (CC) [1]. In cirrhosis, there
is an increased hepatic production of lymph, which may cause distension of
the thin-walled lymphatic channels, particularly if there is increased resistance
at the venolymphatic junction such as due to elevated systemic venous
pressure [2]. Dilatation of porta hilar lymphatics and CC in patients with portal
hypertension has been shown by lymphangiography, endoscopic ultrasound,
and at autopsy [3–7].
The CC is commonly visible on MR images as high-signal intensity (SI) filled
structure on heavily T2-weighted images, with delayed enhancement several
minutes after the intravenous administration of gadolinium contrast agent [8]. In our
current practice at MR imaging, we often noted an enlarged CC in patients with
uncompensated cirrhosis. Thus the purpose of this study was to determine the
frequency of dilated CC on MR images in patients with cirrhosis, and to assess its
value as a simple diagnostic imaging sign of uncompensated cirrhosis.

Material and methods
Patients
From July 2005 through December 2006 at our institution, hepatic MR imaging
reports, clinical MR imaging requests, and patient charts were searched by one
author (S.K.V) to identify patients with cirrhosis and patients without chronic liver
diseases. This retrospective review was conducted according to a protocol approved
by the Institutional Review Board for retrospective review of radiology, clinical, and

pathology records. Informed consent was not required. These cases were then
cross-referenced to the histopathologic records to select patients with pathologically
proved cirrhosis. Patients were excluded if they had a history of hepatic resection,
cholecystectomy, or a malignant hepatic tumor larger than 2 cm, as these may affect
the morphology of cirrhotic liver. In patients having more than one MRI study, the
first MRI study was used for initial analyses.
Consequently, this study population included a total of 257 consecutive patients,
149 with pathologically proved cirrhosis (82 men and 67 women; age range 22–87
years; mean age 52.4 years) and 108 control subjects with no clinical evidence of
chronic liver diseases (63 men and 45 women; age range 22–81 years; mean age
53.3 years). The presence of cirrhosis was documented histologically and/ or by MR
features of cirrhosis, i.e., irregular, nodular liver surfaces with accompanying signs of
portal hypertension such as the presence of ascites, esophageal varices, and/or
splenomegaly. Among 149 cirrhotic patients, 43 patients had compensated cirrhosis
and 106 patients had uncompensated cirrhosis based on the Child-Pugh
classification (Child grades A, B, C) [9, 10]. Uncompensated cirrhosis was defined
as the presence of at least two of the following five criteria: ascites, encephalopathy,
hyperbilirubinemia >3 mg/dL, hypoalbuminemia < 3.2 g/dL, and prothrombin time >3
s [11].
Patients in the control group had undergone MR imaging for reasons other than
chronic liver diseases (e.g., suspected liver cyst or hemangioma, benign disease of
other organs). Reports indicated benign hepatic lesions including hemangioma, cyst,
focal nodular hyperplasia in 59, pancreatic and biliary system abnormality in 19, liver

metastasis in 11, normal in 10, or undetermined due to insufficient clinical data in 9.
Cirrhosis patients had been referred for MR imaging to evaluate the severity of
cirrhosis and portal hypertension, to acquire preoperative studies before liver
transplantation, or to evaluate suspected hepatocellular carcinoma.
One of the authors (S.K.V) retrospectively reviewed all pathology reports that
were entered in the patient’s clinical history. Cirrhosis was caused by viral infection
(hepatitis B [n = 25], C [n = 51], or B and C [n = 19]), alcohol abuse (n = 35), primary
biliary cirrhosis (n = 10), a1-antitripsin deficiency (n = 4), or cryptogenic (n = 5).
Cirrhosis was histopathologically confirmed by means of percutaneous liver biopsy
in 124 patients, liver transplantation in 10, and transjugular liver biopsy in 15. We
were able to determine Child-Pugh classification from the available clinical records in
135 of 149 patients with cirrhosis. Forty-one were classified as having Child A, 18
patients as having Child B, and 76 patients as having Child C. Of 149 cirrhotic
patients, 124 had only one MR examination and 25 had two or more MR
examinations.
MR imaging
All MR examinations were performed during suspended respiration with a 1.5-T
system (Signa; General Electric Medical Systems, Milwaukee, WI, USA; or Intera;
Philips Medical Systems, Best, The Netherlands) and a 4-channel torso phased
array coil. Coronal and transverse two-dimensional single-shot fast spin-echo (FSE)
T2-weighted MR images (effective echo time, 180–200 ms), transverse fat
suppressed FSE T2-weighted (2500–4000/80–90 [repetition time (ms)/echo time
(ms)]), spoiled dual gradient-echo T1-weighted in-and out-of-phase (120–200/2.3

and 4.6 ms, 90º flip angle) MR images were obtained. Parameters for twodimensional images included a section thickness of 5–8 mm with an intersection gap
0–1 mm; a 256 × (160–192) matrix, a 32 cm transverse field of view and 24 cm
anteroposterior field of view, one or fewer signals acquired. Three-dimensional (3D)
dynamic enhanced spoiled gradient-echo dynamic MR images were obtained with 5
mm section thickness in 2.5 mm increments by using zero interpolation, 4–6/3–2.1
and 12–20º flip angle parameters were otherwise similar to those of the twodimensional imaging. Twenty milliliters of gadopentate dimeglumine was
administered intravenously by using a power-injector at 2 mL/s followed by a 20-mL
saline flush. Imaging was initiated at a time intended to optimize first-pass arterial
enhancement by using a timing bolus sequence, or observing the enhancement on
images reconstructed in real-time. In all patients, 3D-gradient echo images were
obtained during breath-hold before (non-enhanced phase), immediately after
(hepatic arterial phase), and 30 s after (portal venous phase) the injection. Delayed
phase (approximately after 3–5 min) images of the entire liver were obtained by
using contiguous 5 mm thick fat suppressed two-dimensional single section
technique (19/2, 30º flip angle), and by using 3D gradient-echo sequence described
earlier. The acquisition of two-dimensional single section delayed phase images was
included in our routine protocol because these images have less motion artifact and
higher vascular SI as compared with 3D delayed phase images.
Review of records and images
Images of subjects in the control and cirrhosis groups were presented to reviewers
in random order. MR images of each patient were evaluated on a computer monitor

on a picture archiving and communication system workstation (Canon Medical
Systems, Irvine, CA, USA) retrospectively and independently by three radiologists
(S.K.V., D.B., and Y.L with 3, 10, and 2 years, respectively, of body MRI experience)
who were blinded to the final diagnosis with regard to the presence of cirrhosis, and
they evaluated the images qualitatively for the presence of CC. When there was
disagreement in their opinions regarding the visibility of CC, a majority opinion was
used as the final decision. CC was considered visible if a ductal or saccular fluid
structure in the prevertebral region below the diaphragm and SI similar to that
cerebrospinal fluid was visualized in the retrocrural space usually to the immediate
right of the abdominal aorta at the level of the L1–L2 vertebral body. In order to
reduce subjective judgments involved with identifying and measuring structures with
diameter less than 2 pixels, we restricted analysis to CCs with in plane diameter of 2
mm or greater. For objectivity and reproducibility of the image analysis performed in
this study, the criteria to identify CC were provided on the basis of features observed
on precontrast and dynamic phase images and of prior published descriptions of the
appearance and enhance- ment characteristics of CC [1]. The radiologists defined a
structure as CC if it showed high SI similar to spinal canal on heavily T2-weighted
single shot FSE images and homogeneous enhancement on delayed phase images
with no enhancement during the arterial and portal venous phases. Lymph nodes,
which also enhance on delayed images, were distinguished from lymphatic channels
due to their enhancement on early phase images, and their SI lower than fluid on
heavily T2-weighted single shot FSE images. Images were reviewed on an
independent imaging workstation. Each reviewer individually chose images for

measurement on the basis of clarity of the landmarks. CCs with minimum
transverse diameter of 2 mm constituted the study group. A cut-off point of 6 mm
was used to define dilated CC [12]. Maximum transverse diameters at its widest part
were recorded on axial heavily T2-weighted single shot FSE using electronic caliber.
Presence or absence of ascites was noted. The growth rate of CC was expressed as
diameter doubling time [13] for the available serial MRI follow-up.
Statistical evaluation
Statistical analysis was conducted using SAS V. 9.13 for Windows (2006; SAS
Institute, Gary, NC, USA). Descriptive statistics (mean, SD) were provided where
appropriate. Comparisons between the frequencies of dilated CC among
compensated vs uncompensated cirrhotic subjects, and CC diameters on serial MRI,
were conducted by using a two-tailed Student t-test. A P-value of less than 0.05
indicated a statistically significant difference. The sensitivity, specificity, accuracy,
and positive predictive value of dilated CC in uncompensated group were also
calculated.

Results

Cisterna chyli maximum transverse diameters were recorded in 113 of 149 (76%)
cirrhotic patients (mean 4.8 mm; range 2–13 mm) and in 15 of 108 (14%) control
subjects (mean 2.4 mm; range 2–4 mm) (P< 0.001). Among the cirrhotic patients,
CCs with maximum transverse diameter ranged from 2 to 11 mm (mean 2.7 mm) in
25 of 43 (58%) compensated and 2 to 13 mm (mean 5.4 mm) in 88 of 106 (83%)

uncompensated cirrhosis patients (P< 0.001) (Table 1). Dilated CCs with maximum
transverse diameter (range 6–13 mm; mean 7 mm) were seen in 2 of 43 (5%) in
compensated and 57 of 106 (54%) in uncompensated cirrhosis patients (P< 0.001)
(Fig. 1) (Table 1). None of the control patients had dilated CC. Between two patients
with compensated cirrhosis with dilated CCs (diameters 11 and 6 mm; mean 8.5
mm), one had associated evidence of right-sided cardiac decompensation (Fig. 2)
and the other had prior history of pancreatitis. The sensitivity, specificity, accuracy,
and positive predictive value of dilated CC for uncompensated cirrhosis were
54%,98%, 80%, and 96%, respectively. Among the 25 patients with serial MRI, the
diameter of the CC on first MR images ranged from 3 to 11 mm (mean 5.6 mm) and
4 to 12 mm (mean 6.6 mm) on last MRI (mean follow-up 282 days) (not significantly
different, P = 0.13). Child-Pugh classification was C in 23 of 25; 2 other patients
progressed from Child B to Child C based on the increase in the bilirubin and
development of ascites. In these two patients, CC diameter on first MRI ranged from
4 to 5 (mean 4.5 mm) and 5 to 6 (mean 6.6 mm) on last MRI (mean follow-up 278
days) (Fig. 3). Interobserver reliability assessment Intraclass correlation coefficient
(ICC) assessment as described by Shrout and Fleiss [14] indicated excellent to
almost perfect agreement. ICC for CC measurement in compensated cirrhosis,
uncompensated cirrhosis, and control subjects were 0.99, 0.97, and 0.98. ICC for
the measurement of dilated CC in compensated cirrhosis, uncompensated cirrhosis,
and control subjects were 1.0, 0.97, and 0.97.

Discussion

The results of the present study confirm the ability to identify CC by MRI in healthy
volunteers and in patients with cirrhosis. Further, dilated CC had high specificity and
positive predictive value for uncompensated cirrhosis, present in 54% of patients
with uncompensated cirrhosis with excellent interobserver agreement.
Few previous studies have reported the imaging appearance of CC [15, 16]; the
frequency of seeing the CC on lymphangiography ranged from 30% to 53% [4], but
only 1.7% on CT [17] On MRI, Erden et al. [18] detected CC in 96% of patients on
heavily T2-weighted images. Unlike these investigators, we used a threshold
diameter of 2 mm for identifying CC because of potential variability in identifying
structures smaller than a pixel. This probably accounted for our lower rate of visible
CC of 76% in cirrhotic patients and 14% of control subjects.
Lymphatics from the lower portion of the body converge in the lumbar region of
the abdominal cavity to form the CC, which extends for about 6 cm just to the right of
the abdominal aorta. At the level of the 12th thoracic vertebra, the CC narrows and
becomes the thoracic duct. In patients with portal hypertension, hepatic hilar
lymphatics become distended and obstruct the hepatic venules. This phenomenon
of increased lymph production in patients with advanced liver diseases is caused by
disturbance in the drainage of vascular flow from the sinusoid to the central or
terminal hepatic veins associated with lobular distortion [7, 19, 20].
We speculate that in uncompensated cirrhosis any rise in pressure in the portal
system will bring about an increase in liver and splanchnic lymph production, which

is a factor responsible for CC dilatation [21, 22]. Little is known about the growth rate
of such lymphatic channels [3]; however, in our study we did not find any significant
change of diameter of CC among 25 patients over the period of less than 1 year.
It should be noted that the CC was visible in 14% of the control subjects. This
may relate to the spectrum of normal physiology, but it is possible that some of these
patients had increased thoracic duct lymph flow due to other conditions such as
pancreatic and biliary obstruction, state of hydration (e.g., right-sided cardiac
decompensation with elevated hepatic venous pressure) [23]. None of the control
patients had CC wider than 6 mm, in contrast to 5% of those with compensated
cirrhosis and 54% with uncompensated cirrhosis. The 54% (57 of 106) sensitivity of
dilated CC for determining uncompensated cirrhosis is relatively low. However, its
high specificity (98%; 149 of 151) renders this sign as complementary to other
findings of uncompensated cirrhosis that may be more sensitive [24, 25].
We acknowledge the following limitations of our study. We did not compare MRI
with another gold standard, but our interobserver agreement for detection rate of CC
among the readers was quite high, with acceptable interobserver agreement. We
were not able to confirm our imaging findings by conventional direct or indirect
portographic methods in patients with portal hypertension. Conventional portography
is invasive and therefore was not performed in most patients. We could not evaluate
changes in visibility of the CC in relation to progression from compensated to
uncompensated cirrhosis, since only short-term follow-up was possible. A further
prospective study would be necessary to determine whether the visibility or diameter
of CC has prognostic significance or can be used to monitor disease progression.

Our control patients were chosen on the basis of imaging technique and period of
imaging identical to that of the patients with cirrhosis. We did not match sex, race, or
socioeconomic status between groups. However, we are not aware of any data to
suggest that CC differs with respect to these variables. Since the control population
was drawn from among people examined with MR imaging performed because they
were suspected of having disease, this population may not be representative of the
general population or of patients without cirrhosis who are at risk for cirrhosis.
Another limitation was that the diameter of CC was determined on the basis of MR
imaging, not by means of histological confirmation. Pathologic proof, however, would
not be practical in the clinical setting.
In conclusion, although CC is commonly visible in subjects without liver disease or
with clinically compensated cirrhosis, dilated CC found at MR is specific for
uncompensated cirrhosis.
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FIGURES & TABLES

Table 1. MRI visualization of cisterna chyli (CC) in 149 patients with compensated and
uncompensated cirrhosis.

Findings Compensated Uncompensated P-value
(n = 43) (n = 106)
CC >2 mm 25 88 <0.001
CC > 6 mm (dilated) 2 57 <0.001
Note: Data are the number of patients

Fig. 1. MR images of cisterna chyli (CC) in a 56-year-old man with uncompensated
cirrhosis. (A) Coronal single-shot FSE T2-weighted MR image (TE 180–200 ms)
shows dilated (8 mm in diameter) hyperintense CC (arrow) in the right retrocrural
space. (B) Axial 3D gradient-echo delayed phase MR image (5/1.4, 12flip angle)
demonstrates dilated CC (8 mm in diameter) (arrowhead) enhancing intensely
similar to surrounding blood vessels. Signs of portal hypertension splenomegaly and
patent paraumblical shunt (arrow) are evident.

Fig. 2. MR images of cisterna chyli (CC) in a 48-year-old man with compensated
cirrhosis and right-sided cardiac decompensation. (A) Axial single-shot FSE T2weighted MR image (TE 180–200 ms) shows dilated (11 mm in diameter)
hyperintense CC (arrow) in the right retrocrural space. (B) Axial 3D gradient-echo
portal venous phase MR image (5/1.4, 12flip angle) shows dilated hepatic veins and
prominent IVC (arrow), consistent with right-sided heart failure/tricuspid
regurgitation.

Fig. 3. MR images of cisterna chyli (CC) in a 47-year-old man with cirrhosis with
clinical progression. (A) Axial single-shot FSE T2-weighted MR image (TE 180–200
ms) shows minimal ascites (arrow) and hyperintense (4 mm in diameter) CC
(arrowhead). (B) Axial single-shot FSE T2-weighted MR image (TE 180–200 ms)
obtained 9 months later shows moderate ascites (arrow) and hyperintense CC with
diameter (5 mm) (arrowhead).

